Literature DB >> 8050183

Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.

D Mitropoulos1, S Kooi, J Rodriguez-Villanueva, C D Platsoucas.   

Abstract

Fresh (uncultured) TIL from 12 untreated patients with primary renal cell carcinoma were prepared from tumour specimens by enzymatic digestion, and were characterized by immunofluorescence using MoAbs recognizing leucocyte differentiation antigens or particular V alpha or V beta segments of the T cell receptor (TCR). These fresh TIL comprised CD3+ (20-84%); CD4+ (3-15%); CD8+ (13-35%); alpha beta TCR+ (20-50%); gamma delta TCR+ (3-17%); CD16+ (1-18%) and CD56+ (3-10%) cells. Significant proportions of V alpha 2+, V beta 5.1+ and V beta 6+ cells were found in TIL of certain patients with renal cell carcinoma, suggesting that they comprised oligoclonal T cells. T cell lines were developed in low concentrations of rIL-2 (200 U/ml) from TIL from 11 patients with renal cell carcinoma, and were characterized by immunofluorescence and cell-mediated cytotoxicity. These T cell lines consisted primarily of CD3+ (51-94%); CD4+ (1-80%); CD8+ (0-84%); alpha beta TCR+ (65-87%); gamma delta TCR+ (0-25%); CD16+ (0-16%) and CD56+ (2-57%) cells. These T cell lines exhibited non-specific cytotoxicity against autologous and allogeneic renal tumour cells, with the exception of one T cell line that exhibited preferential cytotoxicity against autologous renal tumour cells. These results suggest that fresh TIL from patients with renal cell carcinoma contain significant proportions of oligoclonal T cells that may have accumulated at the tumour site as a result of a clonal expansion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050183      PMCID: PMC1534685          DOI: 10.1111/j.1365-2249.1994.tb06088.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.

Authors:  N K Damle; L V Doyle
Journal:  Lymphokine Res       Date:  1989

2.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.

Authors:  S L Topalian; D Solomon; S A Rosenberg
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

3.  Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes.

Authors:  P Ditonno; C L Tso; T Sakata; J B deKernion; A Belldegrun
Journal:  Urol Res       Date:  1992

4.  Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.

Authors:  R S Freedman; B Tomasovic; S Templin; E N Atkinson; A Kudelka; C L Edwards; C D Platsoucas
Journal:  J Immunol Methods       Date:  1994-01-03       Impact factor: 2.303

5.  Lymphokine production by human melanoma tumor-infiltrating lymphocytes.

Authors:  M A Salmeron; T Morita; H Seki; C D Platsoucas; K Itoh
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma.

Authors:  A S Koo; C L Tso; T Shimabukuro; C Peyret; J B deKernion; A Belldegrun
Journal:  J Immunother (1991)       Date:  1991-10

7.  Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs.

Authors:  P F Chen; C D Platsoucas
Journal:  Scand J Immunol       Date:  1992-05       Impact factor: 3.487

8.  Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.

Authors:  A Belldegrun; L M Muul; S A Rosenberg
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

9.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas.

Authors:  D Heinemann; P J Smith; M O Symes
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more
  5 in total

1.  Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

Authors:  K F Yoong; D H Adams
Journal:  Clin Mol Pathol       Date:  1996-10

2.  Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+).

Authors:  S Castle; S Wilkins; E Heck; K Tanzy; J Fahey
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

3.  Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.

Authors:  N Watanabe; A Hizuta; N Tanaka; K Orita
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 4.  Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Authors:  Christiane Geiger; Elfriede Nössner; Bernhard Frankenberger; Christine S Falk; Heike Pohla; Dolores J Schendel
Journal:  J Mol Med (Berl)       Date:  2009-03-07       Impact factor: 4.599

5.  Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.

Authors:  U Elsässer-Beile; M Rindsfüser; T Grussenmeyer; W Schultze-Seemann; U Wetterauer
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.